Advisory Committee on Prescription Medicines (ACPM)

2 December 2014

Role of ACPM

The Advisory Committee on Prescription Medicines (ACPM) was formed in January 2010. The ACPM advises and makes recommendations to the TGA on prescription medicines. This includes:

  • inclusion of a prescription medicine on the Australian Register of Therapeutic Goods (the Register)
  • changes to an entry of a prescription medicine on the Register
  • removal or retention of a prescription medicine on the Register.

ACPM may also provide advice to the Minister or the Secretary, through the TGA on other matters concerning a prescription medicine, and any other matters referred to it by the Minister or the Secretary.

The ACPM is the successor of the Australian Drug Evaluation Committee (ADEC), which was formed in 1963.

Advisory Committee on Prescription Medicines (ACPM) members

Chair

Clinical Associate Professor Geoffrey Herkes is Head of Department of Neurology, Royal North Shore Hospital Sydney, and holds a teaching position at the University of Sydney. He has major research interests in neuropharmacology and epilepsy, as well as in general neurology. He attained his PhD at the University of Queensland and studied at the Mayo Clinic, USA. Associate Professor Herkes has held executive positions on many research and clinical associations and bodies within Australia. He has been a member of ACPM since 1999, and was appointed Chair in 2008. Associate Professor Herkes provides expertise in the field of neurology.

Members

  • Dr Barbara-Ann Adelstein is a Senior Lecturer in Medicine at the Prince of Wales Clinical School, University of NSW. She is a medical practitioner with a broad clinical background, a PhD in epidemiology and experience in medical and health services research. Her interests include improving health outcomes, providing effective health care and using research expertise and evidence-based practice to improve clinical care. Dr Adelstein provides expertise in the field of epidemiology.
  • Ms Kathryn Briant has wide-ranging experience in the health sector including pharmaceutical policy and medication safety. She has particular interests in the Quality Use of Medicines and consumer participation. She has worked previously in the Department of Health and Ageing and for Divisions of General Practice. She is currently a consultant with the consumer health movement. Ms Briant provides expertise in the field of consumer issues.
  • Associate Professor Shane Carney is a nephrologist at John Hunter Hospital and a clinical academic in the Faculty of Medicine and Health Sciences at the University of Newcastle. He has clinical pharmacology expertise in nephrology including transplantation and hypertension. Associate Professor Carney provides expertise in the field of renal disease.
  • Associate Professor Allen Cheng is an infectious diseases physician at the Alfred Hospital and Associate Chair in Infectious Diseases Epidemiology at the Department of Epidemiology and Preventative Medicine at Monash University. Dr Cheng has diverse clinical experience in metropolitan and regional hospitals in Australia, research interests in clinical infectious diseases, infection control and public health epidemiology. Associate Professor Cheng provides expertise in the fields of infectious diseases and biostatistics.
  • Dr Alison Davis is a senior staff specialist in medical oncology at the Canberra Hospital, and senior lecturer in medical oncology at the Australian National University's medical School. She is actively involved in clinical research with a sub-speciality interest in breast and gynaecological malignancies. Dr Davis provides expertise in the field of oncology.
  • Dr Jane Goddard is a general practitioner and women's health physician with broad experience in rural, regional and remote medicine. She has interests in quality use of medicines, evidence based practice and research in primary care. She has long been actively involved in committees concerning all of these areas. Dr Goddard provides expertise in the field of general medical practice.
  • Dr Richard Halliwell is the Director of the Acute Pain Service, Westmead Hospital, Deputy Director of the Anaesthesia Department Westmead Hospital, Chair of Westmead Hospital Safe Use of Medicines Committee, Deputy Chair of the Western Sydney Local Health District Drug Committee and a Clinical Senior Lecturer, Sydney Medical School, University of Sydney. He also has experience and interest in clinical pharmacology and clinical trials. Dr Halliwell provides expertise in general and regional anaesthesia and pain management.
  • Associate Professor Jane Hanrahan is a medicinal chemist in the Faculty of Pharmacy at the University of Sydney. Her research interests currently include the medicinal chemistry and pharmacology of neurologically active drugs and the isolation and identification of natural products with neurological and anti-cancer activities. Associate Professor Hanrahan provides expertise in the field of pharmaceutical chemistry.
  • Associate Professor Catherine Hill is a consultant rheumatologist at the Queen Elizabeth Hospital in Adelaide and holds a teaching and research position in medicine at the University of Adelaide. Associate Professor Hill has extensive experience in clinical trials, holds a Master of Science degree majoring in epidemiology from Boston University, USA and an MD from the University of Adelaide. Her current research interests are in the epidemiology of musculoskeletal disorders, clinical trial methodology, osteoarthritis and temporal arthritis. Associate Professor Hill provides expertise in rheumatology.
  • Dr Robert Hitchins is a medical oncologist and palliative care physician from the Gold Coast. After training in Brisbane, Sydney and London, he commenced specialist practice on the Gold Coast in 1988 and held a range of public and private hospital positions, which included establishing the first palliative care service in the region. He currently teaches at Bond University Medical School, has a keen interest in the quality use of medicines, and writes extensively on medical matters. Dr Hitchins provides expertise in the fields of oncology and haematology.
  • Dr Andrew Jabbour is a consultant cardiologist at St Vincent's Hospital, Sydney. After completing cardiology training at St Vincent's, Dr Jabbour undertook a PhD at the Victor Chang Cardiac Research Institute before moving to the United Kingdom to complete post-doctoral research at The Royal Brompton Hospital and Imperial College London. He is a senior lecturer with the University of New South Wales and has an interest in cardiomyopathy. Dr Jabbour provides expertise in the field of cardiology.
  • Professor Stewart Kellie is a paediatric oncologist at The Children's Hospital, Westmead and Clinical Professor in the Discipline of Paediatrics and Child Health at the University of Sydney. He has a particular interest in neuro-oncology in infants and children and has an MD for his thesis titled 'Advances in Paediatric Neuro-Oncology'. He has an ongoing interest in training fellows from developing countries. Professor Kellie provides expertise in the fields of oncology and paediatrics.
  • Dr Debra Kennedy is a Paediatrician and Clinical Geneticist. She established and is the Director of MotherSafe which is a statewide NSW service that provides evidence-based advice and counselling to both consumers and health care providers regarding medication and other exposures during pregnancy and breast feeding. Dr Kennedy is involved in clinical practice and research as well as being a conjoint lecturer in the School of Women's and Children's Health at UNSW. Dr Kennedy provides expertise in the field of paediatrics.
  • Professor Harry McConnell is a neuropsychiatrist with specific expertise in neurodisability and epilepsy, with broad international experience. Professor McConnell is currently Director of Neurosciences at St Vincent's Hospital Brisbane and the Clinical Subdean at Gold Coast University Hospital and Griffith University School of Medicine where he is also Professor of Neuropsychiatry and Neurodisability. He is Chair of the South East Queensland Disability Advisory Council and a member of the Queensland Disability Advisory Council. Professor McConnell provides expertise in the field of psychiatry.
  • Dr Elizabeth Merson has over 30 years of experience as a consultant physician. Her interest is in geriatric medicine, particularly in the areas of alzheimer’s disease and dementia. She is currently in private practice on the Gold Coast servicing a large elderly population of the region. Dr Merson has held several teaching positions and is currently an Assistant Professor with Bond University, Gold Coast. Dr Merson provides expertise in the field of gerontology.
  • Associate Professor Anne Mijch OAM is a consultant infectious diseases specialist with special interest in HIV, STIs and Hepatitis. She established HIV services at Fairfield Infectious Diseases Hospital then transferred these to Alfred Hospital in Melbourne as Head of Victorian HIV Service. Associate Professor Mijch has been recognised for her work in HIV/AIDS and was awarded the Medal of the Order of Australia for her services to medicine in this field. She is now working as Consultant and Mentor in Infectious Diseases and HIV in SE Asia and Oceania, as Adjunct Professor at Monash University and as a Senior Principal Fellow within the Burnet Institute. Associate Professor Mijch provides expertise in the field of infectious diseases.
  • Dr Stephen Phillips OAM is a General Practitioner with long interest in standards and quality, particularly in relation to medicines, therapeutics and public health. Dr Phillips actively participates on a variety of committees and medical professional organisations. He has the Medal of the Order of Australia for his services as a promoter of the safe and effective use of medicines. Dr Phillips provides expertise in the field of general medical practice.
  • Associate Professor Peter Pillans is a specialist in clinical pharmacology, Associate Professor in the Department of Medicine, University of Queensland and currently the Director of Clinical Pharmacology and a specialist physician at Princess Alexandra Hospital. He has a particular interest in drug safety and served on the New Zealand Medicines Adverse Reactions Committee and the Australian Adverse Drug Reactions Advisory Committee for many years. He chairs numerous hospital drug committees and is deputy chair of the Queensland Hospitals Medicines Advisory Committee. Associate Professor Pillans provides expertise in the fields of clinical pharmacology and pharmaceutical chemistry.
  • Dr John Riley is the Head of Department of Gastroenterology, Royal North Shore Hospital, Sydney and also holds a teaching position at the University of Sydney. He has a Doctorate of Medicine from the University of Sydney based on research carried out at Columbia Medical Centre, New York, USA. Dr Riley has been an active member of the Gastroenterology Department at Royal North Shore Hospital for many years. Having a particular interest in small bowel disease, inflammatory bowel disease and endoscopy, Dr Riley provides expertise in the field of gastroenterology and hepatology.
  • Dr Helen Ritchie is a Senior Lecturer in Anatomy at the Sydney Medical School. Her major research interest is in developmental toxicology with a particular interest in drugs with cardiovascular effects. She also has interests in reproductive toxicology and complementary medicines. She is the current President of the Australian Birth Defects Society. Dr Ritchie provides expertise in the field of toxicology.
  • Associate Professor Philip Robinson is a specialist paediatric respiratory physician at the Royal Children's Hospital, Victoria and Head of the Hospitals Cystic Fibrosis Service. Associate Professor Robinson provides expertise in the fields of respiratory disease and paediatrics.
  • Associate Professor David Smallwood is a specialist adult respiratory physician at the Royal Melbourne Hospital and has a PhD on airway remodelling in asthma. He has also undertaken extensive research into chronic obstructive pulmonary disease. Associate Professor Smallwood has experience in cardiac respiratory medicine and pulmonary hypertension. Associate Professor Smallwood provides expertise in the field of respiratory disease.
  • Dr Kee Meng Tan is a consultant neurologist trained at Royal Brisbane & Women's Hospital and Mayo Clinic (USA), with specific expertise in epilepsy and autoimmune neurological disease. He is currently a member of The Royal Melbourne Hospital's comprehensive epilepsy program and is engaged in research into inflammatory aspects of epilepsy. Dr Tan provides expertise in the field of neurology.
  • Dr Heather Tapp is a consultant paediatric haematologist/oncologist employed at the Women's and Children Hospital, Adelaide. She is a Fellow of the Royal College of Pathologists of Australia and the Royal Australasian College of Physicians, and is also a member of several haematology and oncology groups worldwide. Dr Tapp is a senior adjunct lecturer at the University of South Australia. Dr Tapp provides expertise in the fields of paediatrics; haematology and oncology.
  • Professor Duncan Topliss is Director of Endocrinology & Diabetes at the Alfred Hospital, and has clinical and research interests across endocrinology including diabetes, thyroid disease and bone disease. Professor Topliss has extensive experience in medical and scientific issues in the interests of drug regulation and is also a member of the TGA Advisory Committee on Safety of Medicines. Professor Topliss provides expertise in the fields of endocrinology and pharmacokinetics.
  • Associate Professor Beverley Vollenhoven is a gynaecologist and holds a teaching position in the Department of Obstetrics and Gynaecology, Monash University and is Director of Gynaecology, Southern Health, Melbourne. She is also a reproductive endocrinologist and infertility specialist and a clinician at Monash IVF. Associate Professor Vollenhoven provides expertise in the field of gynaecology/reproductive medicine.
  • Dr Dominica Zentner is an adult cardiologist at the Royal Melbourne Hospital with a PhD on cardiac changes during normal human pregnancy. Her clinical practice encompasses general clinical cardiology, adult congenital heart disease, the management of women with cardiac disease during pregnancy, genetic cardiology and echocardiography. She is involved in clinical research in these areas. Dr Zentner provides expertise in the field of cardiology.
  • Professor John Ziegler AM is Head of the Department of Immunology and Infectious Diseases and of the HIV Service, Sydney Children's Hospital. His current research interests include genetics of primary immune deficiency disorders (PID), long term outcomes for children with PID; and severe food allergy in Australian children. Dr Ziegler is a Fellow of the Royal Australasian College of Physicians and cofounder of the Australasian Society for HIV Medicine. He also serves on NSW Department of Health Anaphylaxis Education Governing Group and chairs the Immunoglobulin User Group for NSW Health. Associate Professor Ziegler provides expertise in the field of immunology.

ACPM meeting dates

ACPM planned meeting dates 2015

Meeting no. Cut-off date for pre-ACPM response Meeting date
2015/1 (302) 20 January 2015 6 February 2015
2015/2 (303) 24 March 2015 10 April 2015
2015/3 (304) 19 May 2015 5 June 2015
2015/4 (305) 21 July 2015 7 August 2015
2015/5 (306) 15 September 2015 2 October 2015
2015/6 (307) 17 November 2015 4 December 2015

ACPM Pharmaceutical Subcommittee (PSC)

The Pharmaceutical Subcommittee makes recommendations to ACPM and the TGA on the pharmaceutical chemistry, quality control, bioavailability and pharmacokinetics of prescription medicines proposed for registration in Australia.

ACPM Pharmaceutical Subcommittee (PSC) members

Chair

Professor Andrew McLachlan has expertise in clinical and experimental pharmacology. He is Professor of Pharmacy (Aged Care) in the Faculty of Pharmacy at the University of Sydney, and the Centre for Education and Research on Ageing at the Concord Repatriation General Hospital, NSW. Professor McLachlan's research interests include understanding the causes and consequences of variability in response to medicines and how this informs their quality use.

Members

  • Associate Professor Mary Collins is a specialist in medicinal chemistry and molecular pharmacology. She is Professor of Pharmaceutical Neuroscience in the Faculty of Pharmacy at the University of Sydney. Associate Professor Collins' research interests include medicinal chemistry and molecular pharmacology of GABA-A and nicotinic acetylcholine receptors. She has published approximately 100 refereed international publications, and is the recipient of a number of scientific awards for her research.
  • Professor Andrew Davey is a specialist in pharmacokinetics and biopharmaceutics. He is the Head of the School of Pharmacy at Griffith University. Professor Davey has previously worked at the University of South Australia, Otago University, as a consultant to the Centre of Pharmaceutical Research and within community pharmacy. He has authored over 80 significant research publications including peer-reviewed research papers, industry reports and textbook chapters in the areas of pharmacokinetics, inflammation, pharmaceutical sciences, and education.
  • Dr David Foster is a specialist in pharmacometrics and biopharmaceutics. He is a Senior Lecturer in pharmacokinetics in the School of Pharmacy and Medical Sciences at the University of South Australia. Dr Foster is a member of the Drug and Therapeutics Committee (Clinical Trial Group) of the Children, Youth and Women's Health Service, South Australia.
  • Professor Beverley Glass is specialist in Pharmaceutical Chemistry. She is a recognised expert in Drug Stability, in particular Photostability, and is currently the Chair of Pharmacy in the College of Medicine and Dentistry at James Cook University. Professor Glass' main research interests centre on in-use drug stability and the impact of extreme environmental conditions of light, heat and humidity on the storage and use of medicines, to ensure their quality especially in the Tropics.
  • Professor Jane Hanrahan is a specialist in pharmaceutical chemistry. She is a medicinal chemist in the Faculty of Pharmacy at the University of Sydney. Professor Hanrahan's research interests include the medicinal chemistry and pharmacology of neurologically active drugs and the isolation and identification of natural products with neurological and anti-cancer activities.
  • Dr Stefanie Hennig is a specialist in clinical pharmacokinetics and pharmacodynamics. She is a Lecturer in the School of Pharmacy at the University of Queensland. Dr Hennig's research interests apply pharmacometric methods to improve dosing strategies and clinical outcomes using a model based analysis approach. Her research has led to improved dosing regimens for antimicrobial drugs, changed dosing guidelines and improved therapeutic drug monitoring procedures.
  • Clinical Associate Professor Geoffrey Herkes is a specialist in neurology. He is a Clinical Associate Professor at the University of Sydney, former Head of the Department of Neurology at the Royal North Shore Hospital, and has a teaching position at the University of Sydney. He has a major research interest in neuropharmacology and epilepsy as well as in general neurology. He attained his PhD at the University of Queensland and studied at the Mayo Clinic, USA. Clinical Associate Professor Herkes has been a member of ACPM (previously ADEC) since 1999 and was appointed as the Chair in 2008.
  • Professor Carl Kirkpatrick is a specialist in pharmacometrics and biopharmaceutics. He is the Director of the Centre for Medicine Use and Safety at Monash University. Professor Kirkpatrick is a councillor of the Australasian Society of Clinical and Experimental Pharmacology and Toxicology (ASCEPT) and the secretary of the Population Approach Group in Australia and New Zealand.
  • Professor Ross McKinnon is a specialist in pharmaceutical biotechnology and molecular oncology. He is Director of the Flinders Centre for Innovation in Cancer and Professor of Cancer Research in the School of Medicine at Flinders University. Professor McKinnon is a Vice-President of the International Pharmaceutical Federation (FIP) and a Director of the Australian Institute of Policy and Science.
  • Professor Iqbal Ramzan is a specialist in drug pharmacokinetics and pharmacodynamics and biopharmaceutics. He is an international leader in pharmacy education and has published over 140 refereed papers. Professor Ramzan is the Director of the Council of Pharmacy Schools (Australia and New Zealand) and serves on the Accreditation Committee of the Australian Pharmacy Council. Professor Ramzan is a registered Pharmacist and holds a Diploma from the Australian Institute of Company Directors.
  • Professor Michael Roberts is a specialist in biopharmaceutics and clinical pharmacokinetics. He is a Senior Principal Research Fellow of the National Health and Medical Research Council and Professor of Therapeutics and Pharmaceutical Science at the University of South Australia. As well as, Professor of Clinical Pharmacology and Therapeutics and Director of the Therapeutics Research Centre at the University of Queensland. Professor Roberts has published more than 430 peer-reviewed papers, and has received many awards.
  • Dr Desmond B Williams is a specialist in pharmaceutical chemistry, biopharmaceutics and drug product assessment. He is the Program Director of Pharmaceutical Sciences at the University of South Australia. Dr Williams is a Fellow of the Royal Australian Chemical Institute, a Fellow of the Australian College of Pharmacy, and a member of the Examination Editorial Group, Australian Pharmacy Council, AusBiotech, the American Association of Pharmaceutical Scientists and the Australasian Pharmaceutical Science Association.
  • Associate Professor Erica Wood is a specialist in transfusion medicine. She is a consultant haematologist for Bayside/Southern Health in Melbourne, and an honorary consultant haematologist at The Royal Melbourne Hospital and the Peter MacCallum Cancer Centre. She is past President of the Australian and New Zealand Society of Blood Transfusion, and Chair of the Blood Matters Serious Transfusion Incident Reporting haemovigilance program expert group. Associate Professor Wood is also a member of several international committees and boards specialising in transfusion medicine issues.

ACPM Pharmaceutical Subcommittee (PSC) meeting dates

PSC planned meeting dates 2015

Meeting no. Meeting date
2015/1 (160) Tuesday, 27 January 2015
2015/2 (161) 23 March 2015
2015/3 (162) 25 May 2015
2015/4 (163) 27 July 2015
2015/5 (164) 21 September 2015
2015/6 (165) 23 November 2015

Contacting ACPM

To contact the Advisory Committee on Prescription Medicines

Email
Phone +61 2 6232 8024
Fax +61 2 6203 1250
Postal address Therapeutic Goods Administration
ACPM Secretariat
PO Box 100
Woden ACT 2606
Australia

Top of page